These nanoparticles induced glioma-associated myeloid cell phagocytosis of tumor cells via CD47–PD-L1 ligation, and activation of T cell–supportive myeloid cell phenotypes due to STING agonist–mediated effects. This evidence concerns the gene CD47 and neoplasm.